Description
Fypod-D Tablets – Cefpodoxime & Dicloxacillin (ER) Tablets
Fypod-D Tablets are designed to provide broad-spectrum antibacterial coverage by combining Cefpodoxime and Dicloxacillin (ER). This dual-action formulation targets both common and resistant bacterial strains, making it suitable for treating a variety of infections, including respiratory, urinary, skin, and soft tissue infections. The extended-release Dicloxacillin ensures sustained therapeutic levels, improving patient compliance and efficacy.
Indications / Benefits
Treats respiratory tract infections including bronchitis, pneumonia, and sinusitis.
Effective for urinary tract infections and genitourinary infections.
Manages skin and soft tissue infections such as cellulitis, abscesses, and impetigo.
Treats ear, nose, and throat infections including tonsillitis and otitis media.
Provides broad-spectrum antibacterial activity, including coverage against penicillin-resistant bacteria.
Extended-release formulation supports better adherence and sustained therapeutic action.
